Back to search
Symptomatic Parkinson Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Symptomatic Parkinson Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Symptomatic Parkinson Disease trials you may qualify forThe aim of this phase Ila trial is to provide evidence on safety, tolerability and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with early Par…
The PD-HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support hemodynamic management in…
The primary objective of this study is to assess the safety and tolerability of exidavnemab after multiple dosing versus placebo.
REM Behavior Sleep Disorder (RBD) is a sleep disorder causing people to 'act out' their dreams. A high percentage of individuals with idiopathic RBD (iRBD) are…
Parkinson's disease (PD) is characterized by many non-motor symptoms that occur several years before the diagnosis, in particular idiopathic REM behavior disord…